MARKET

INNMF

INNMF

Amplia Therapeutics Ltd
OTCMQB
0.110
NaN%
Closed 09:30 07/10 EDT
OPEN
--
PREV CLOSE
0.110
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.256
52 WEEK LOW
0.070
MARKET CAP
56.46M
P/E (TTM)
-9.7345
1D
5D
1M
3M
1Y
5Y
1D
Amplia Announces Publication of New FAK Inhibitor Patent Application
Barchart · 1d ago
Amplia Therapeutics appoints Brett Carter as non-executive director
PUBT · 3d ago
AMPLIA ANNOUNCES APPOINTMENT OF BRETT CARTER TO BOARD
Reuters · 3d ago
Amplia Therapeutics names Jane Bell chair as Warwick Tong steps down
PUBT · 4d ago
Amplia Announces Changes to Board’s Leadership Roles
Barchart · 4d ago
Amplia Therapeutics appoints Brett Carter as director amid progress in pancreatic cancer trials
TipRanks · 4d ago
Amplia Therapeutics appoints Brett Carter as non-executive director to board
PUBT · 5d ago
Amplia strengthens board with industry deal-maker Brett Carter
TipRanks · 5d ago
More
About INNMF
Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. Its pipeline includes narmafotinib (AMP945) and AMP886. Its lead drug candidate, narmafotinib, is a selective and potent inhibitor of FAK and is currently in a phase 2 clinical trial for pancreatic cancer, in clinical development for ovarian cancer, and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company’s second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue.

Webull offers Amplia Therapeutics Ltd stock information, including OTCMQB: INNMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INNMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INNMF stock methods without spending real money on the virtual paper trading platform.